Telomere dysfunction and tumour suppression: The senescence connection

334Citations
Citations of this article
367Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Long-lived organisms such as humans have evolved several intrinsic tumour suppressor mechanisms to combat the slew of oncogenic somatic mutations that constantly arise in proliferating stem-cell compartments. One of these anticancer barriers is the telomere, a specialized nucleoprotein complex that caps the ends of eukaryotic chromosome. Impaired telomere function activates the canonical DNA damage response pathway that engages p53 to initiate apoptosis or replicative senescence. Here, we discuss how p53-dependent senescence induced by dysfunctional telomeres may be as potent as apoptosis in suppressing tumorigenesis in vivo. © 2008 Nature Publishing Group.

Cite

CITATION STYLE

APA

Deng, Y., Chan, S. S., & Chang, S. (2008, June). Telomere dysfunction and tumour suppression: The senescence connection. Nature Reviews Cancer. https://doi.org/10.1038/nrc2393

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free